New Stock News | Plai Pharmaceuticals Plans Hong Kong IPO, China Securities Regulatory Commission Requires Supplementary Information on Compliance of Overseas Subsidiary's Foreign Exchange Management

According to the securities times app, on June 5th, the China Securities Regulatory Commission released the "Supplementary Materials Requirements for Overseas Issuance and Listing Filings (June 1, 2026 - June 5, 2026)". The CSRC's International Department issued supplementary material requirements for 10 companies. Among them, Pral Pharmaceutical is required to provide additional information on the specific implementation of regulatory procedures related to overseas investments, foreign exchange management, and other matters by its overseas subsidiaries. According to the disclosure on February 13 by the Hong Kong Stock Exchange, Pral Pharmaceutical submitted an application for listing on the main board of the Hong Kong Stock Exchange, with CITIC Securities as its sole sponsor.